Listed by the USPTO as SHI, GENBIN
Tech Center 1600 • Art Units: 1600 1628
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18843599 | USE OF IPTACOPAN FOR THE TREATMENT OF LUPUS NEPHRITIS | Non-Final OA | Novartis AG |
| 18934671 | COMPOSITIONS AND METHODS FOR TREATING PAIN | Non-Final OA | UNDAUNTED BIO, INC. |
| 18392229 | USE OF L-ERGOTHIONEINE FOR ALLEVIATING AND PREVENTING AGE-RELATED VISUAL DEGENERATION | Final Rejection | NANJING NUTRABUILDING BIO-TECH CO., LTD. |
| 18849136 | METHOD FOR SYNTHESIZING 7-KETOLITHOCHOLIC ACID INTERMEDIATE AND USE THEREOF | Non-Final OA | SUZHOU ENTECH NEW-MATERIAL TECHNOLOGY CO., LTD |
| 18840042 | MODULATION OF HUMAN BREAST MILK COMPOSITION | Non-Final OA | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER |
| 18293329 | MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE | Non-Final OA | Neurocrine Biosciences, Inc. |
| 18716156 | FUSED HETEROCYCLIC COMPOUNDS AS PI3KALPHA INHIBITORS | Non-Final OA | Nanjing Zenshine Pharmaceuticals Co., Ltd. |
| 18712285 | INDOLINES AS PROTAC COMPOUNDS | Non-Final OA | NeoPhore Limited |
| 18691820 | SUBSTITUTED 1,4-DIHYDRO-1,6-NAPHTHYRIDINE AMIDE AND USE THEREOF | Non-Final OA | Tuojie Biotech (Shanghai) Co., Ltd. |
| 18516608 | PREPARATION AND ACTIVITY CHARACTERIZATION OF CANNABICITRAN ENANTIOMERS | Non-Final OA | University of North Carolina at Wilmington |
| 18517390 | EIF4E INHIBITORS AND USES THEREOF | Non-Final OA | PIC Therapeutics, Inc. |
| 18512098 | Larotrectinib and moderate CYP3A4 inducer | Non-Final OA | Bayer Consumer Care AG |
| 18558763 | Diazepane Derivatives, Processes for their Preparation, and Uses thereof for the Amelioration, Prevention and/or Treatment of Mental and Neurological Diseases | Non-Final OA | 2N Pharma ApS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your StrategyGenbin Shi examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
